https://doctransparency.com/doctor/fl/orlando/omer-abdul-hamid-1780048397
Medicare Enrolled

Dr. Omer Abdul Hamid

Neuromuscular Medicine (Psychiatry & Neurology) Physician · Orlando, FL
Research-focused
6535 NEMOURS PKWY, Orlando, FL 32827
4075674000
In practice since 2016 (9 years)
NPI: 1780048397 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abdul Hamid from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abdul Hamid? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abdul Hamid

Dr. Omer Abdul Hamid is a neuromuscular medicine (psychiatry & neurology) physician in Orlando, FL, with 9 years in practice.

Between the years covered by Open Payments, Dr. Abdul Hamid received a total of $211,303 from 22 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neuromuscular medicine (psychiatry & neurology) physician. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abdul Hamid is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice$ $211,303 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$211,303
Total received (2021-2024)
Avg $52,826/year across 4 years
Top 12% in FL for neuromuscular medicine (psychiatry & neurology) physician
22
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$90,000 (42.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$87,700 (41.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$29,202 (13.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,400 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$74,974
2023
$45,742
2022
$556
2021
$90,030

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$116,807
Genentech USA, Inc.
$53,249
Sarepta Therapeutics, Inc.
$20,822
CATALYST PHARMACEUTICALS, INC.
$7,559
PTC Therapeutics, Inc.
$4,680
PFIZER INC.
$3,823
ITF Therapeutics LLC
$1,287
Genentech, Inc.
$916
LivaNova USA, Inc.
$733
NS Pharma, Inc.
$326
Marinus Pharmaceuticals, Inc.
$255
UCB, Inc.
$238
ACADIA Pharmaceuticals Inc
$237
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$116
Catalyst Pharmaceuticals, Inc.
$80
Novartis Pharmaceuticals Corporation
$31
Eisai Inc.
$30
Biocodex, Inc.
$29
JAZZ PHARMACEUTICALS INC.
$26
Jazz Pharmaceuticals Inc.
$23
Azurity Pharmaceuticals, Inc.
$17
Neurelis, Inc.
$17
Top 3 companies account for 90.3% of total payments
Associated products mentioned in payments ›
AGAMREE · Briviact · DAYBUE · DIACOMIT · EPIDIOLEX · Elevidys · Eprontia · Evrysdi · FIRDAPSE · Fycompa · SKYCLARYS · SPINRAZA · Spinraza · VALTOCO · VILTEPSO · VNS Therapy · ZOLGENSMA · ZTALMY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (43%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work.

Looking for a neuromuscular medicine (psychiatry & neurology) physician in Orlando?
Compare neuromuscular medicine (psychiatry & neurology) physicians in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neuromuscular medicine (psychiatry & neurology) physicians nearby

Geographic Context

Neuromuscular Medicine (Psychiatry & Neurology) Physicians within 10 mi
3
Per 100K population
0.2
County median income
$77,011
Nearest hospital
UCF LAKE NONA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abdul Hamid is a neuromuscular medicine (psychiatry & neurology) physician, and high industry engagement (research-focused, top 12%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Abdul Hamid receive payments from pharmaceutical companies?
Yes. Dr. Abdul Hamid received a total of $211,303 from 22 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Abdul Hamid) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →